ORLANDO (July 16, 2008)—Are feelings of depression overwhelming you? Is your self-esteem an issue? Having problems advancing in life or your career? Maybe you feel nervous or self conscious in social settings? Do you avoid social settings all together? Check your smile; tooth loss could be the culprit and you're not alone. Nearly 20 million teeth are extracted each year leaving scores of people to deal with the psychological affects of a less than perfect smile. However, during the Academy of General Dentistry's (AGD) 56th Annual Meeting & Exhibits in Orlando, Fla., July 16-20, H.
While some states are taking adequate steps to address the cost of retiree health-care benefits, others including New Jersey, New York, California and North Carolina are facing tens of billions of dollars in so-called "unfunded liabilities." The myths and realities of this potential crisis are laid out in a new issue brief written by Dr. Robert Clark, a professor of economics and of management, innovation and entrepreneurship at North Carolina State University, and released by the Center for State and Local Government Excellence.
PROVIDENCE, R.I. Researchers at Rhode Island Hospital have identified two potential molecular markers that may predict outcomes for patients with stomach cancer, one of the most common and fatal cancers worldwide.
According to the study, published in the July 1 issue of Clinical Cancer Research, patients who had poor outcomes following surgery for stomach cancer also had extremely low amounts of two proteins, known as gastrokine 1 and 2 (GKN1 and GKN2), which are produced by normal stomach cells.
Scientists at Georgia Tech have developed a potential new treatment against cancer that attaches magnetic nanoparticles to cancer cells, allowing them to be captured and carried out of the body. The treatment, which has been tested in the laboratory and will now be looked at in survival studies, is detailed online in the Journal of the American Chemical Society.
PHILADELPHIA Researchers have determined a novel mechanism through which organ transplantation often leads to cancer, and their findings suggest that targeted therapies may reduce or prevent that risk.
In the July 15, 2008, issue of Cancer Research, researchers at Harvard Medical School found in animal and laboratory experiments that the anti-rejection, immunosuppressive drug cyclosporine ramps up expression of vascular endothelial growth factor (VEGF), which signals the growth of new blood vessels that can feed tumors.
A study by researchers in Thailand, Japan, and the UK has shown a negative correlation between dengue hemorrhagic fever (DHF) and the density of the Aedes mosquitoes that transmit the virus. The study, published July 16th in the open-access journal PLoS Neglected Tropical Diseases, explains how current efforts to reduce the mosquitoes may actually increase the incidence of the potentially fatal viral disease.
A University of California, San Diego School of Medicine researcher has developed the first tissue culture of normal, human liver cells that can model infection with the Hepatitis C virus (HCV) and provide a realistic environment to evaluate possible treatments. The novel cell line, described in the July 16 issue of PLoS ONE, will allow pharmaceutical companies to effectively test new drug candidates or possible vaccines for the HCV infection, which afflicts about 170 million people worldwide. Currently, there is no animal model that is effective for testing such therapies.
Female monkeys are more dominant when they live in groups with a higher percentage of males. This is caused by self-organisation. This surprising discovery was made by researchers at the University of Groningen. What makes the study particularly interesting is that the researchers used a computer model which can simulate interaction between monkeys. Their findings will be published on July 16 in the open-access journal PLoS ONE.
As frog populations die off around the world, researchers have identified certain genes that can help the amphibians develop resistance to harmful bacteria and disease. The discovery may provide new strategies to protect frog populations in the wild.
New work, published in the online, open-access journal PLoS ONE, examines how genes encoding the major histocompatibility (MHC) complex affect the ability of frogs to resist infection by a bacterium that is commonly associated with frog population declines.
Resistance to ciprofloxacin, a member of one of the most commonly used groups of antibiotics in the world, has been discovered by a team of Canadian researchers among people in remote South American villages who are believed to have never taken this medication. The findings are published July 16 in the online, open-access journal PLoS ONE.